Xiaowei Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaowei Zhang has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Tao Xu
Department of Urology, Peking University People’s Hospital, Beijing, China
10 shared publicationsQing Li
Peking University People's Hospital
9 shared publicationsWenjun Bai
Department of Urology Peking University People's Hospital Beijing China
5 shared publicationsYuan Quan
Department of Urology Peking University People's Hospital Beijing China
3 shared publicationsHailong He
Department of Urology, Peking University People’s Hospital, Beijing, China
2 shared publicationsMin Zhang
Department of Urology, Chengdu Kowloon Hospital, Chengdu 614000, China
2 shared publications
Latest Publications
- Open Access
- 11 May 2023
- Published by Springer Nature in Research Square
One-stage Circumcision and Hyaluronic acid injections for Men Reporting Small Penis with Redundant Prepuce or Phimosis
Background The efficacy and safety of filler injection were approved and have become the main choice for penile augmentation (PA). Traditionally, the PA for patients with phimosis or redundant prepuce has been a two-stage surgery-male circumcision first and hyaluronic acid (HA) injections then. We introduced a one-stage procedure for these patients to reduce the cost and recovery time.Methods Eighty-three men who received one-stage male circumcision and HA injection simultaneously in a regional hospital from January 2018 to December 2019 were retrospectively reviewed. In the male circumcision, the penile skin was sharply resected to preserve the integrity of the superficial fascia. HA was injected into the space between the superficial fascia and the deep fascia of the penis. Patients were followed up at 3 months, 6 months, and 12 months after the surgery. Penile maximal girth, patients’ satisfaction level for (using a 5-point scale, with 1 indicating very dissatisfied and 5 indicating very satisfied.) penile appearance and surgical complications were recorded during follow-up.Results Eighty-three men (aged 35.72 ± 4.73 years) received one-stage male circumcision and HA injection surgery. The dosage of HA was 16.10 ± 2.32 ml. The penile maximal girth growth was 2.33 ± 1.27 cm, 1.80 ± 1.11 cm, and 1.31 ± 0.71 cm at the 3-month, 6-month, and 12-month follow-ups, respectively. The satisfaction level for penile appearance was 2.5 ± 0.9 on the final follow-up The complications included 1 (1.2%) infection and 1 subcutaneous bleeding (1.2%). No HA leakage happened.Conclusion One-stage simultaneous male circumcision and HA injection were proven to ensure surgical efficacy and safety for men reporting a small penis with redundant prepuce or phimosis.
- 11 May 2023
- Published by Springer Nature in Research Square
Open AccessOne-stage Circumcision and Hyaluronic acid injections for Men Reporting Small Penis with Redundant Prepuce or Phimosis
Background The efficacy and safety of filler injection were approved and have become the main choice for penile augmentation (PA). Traditionally, the PA for patients with phimosis or redundant prepuce has been a two-stage surgery-male circumcision first and hyaluronic acid (HA) injections then. We introduced a one-stage procedure for these patients to reduce the cost and recovery time.Methods Eighty-three men who received one-stage male circumcision and HA injection simultaneously in a regional hospital from January 2018 to December 2019 were retrospectively reviewed. In the male circumcision, the penile skin was sharply resected to preserve the integrity of the superficial fascia. HA was injected into the space between the superficial fascia and the deep fascia of the penis. Patients were followed up at 3 months, 6 months, and 12 months after the surgery. Penile maximal girth, patients’ satisfaction level for (using a 5-point scale, with 1 indicating very dissatisfied and 5 indicating very satisfied.) penile appearance and surgical complications were recorded during follow-up.Results Eighty-three men (aged 35.72 ± 4.73 years) received one-stage male circumcision and HA injection surgery. The dosage of HA was 16.10 ± 2.32 ml. The penile maximal girth growth was 2.33 ± 1.27 cm, 1.80 ± 1.11 cm, and 1.31 ± 0.71 cm at the 3-month, 6-month, and 12-month follow-ups, respectively. The satisfaction level for penile appearance was 2.5 ± 0.9 on the final follow-up The complications included 1 (1.2%) infection and 1 subcutaneous bleeding (1.2%). No HA leakage happened.Conclusion One-stage simultaneous male circumcision and HA injection were proven to ensure surgical efficacy and safety for men reporting a small penis with redundant prepuce or phimosis.
- Open Access
- 1 April 2023
- Published by Springer Nature in BMC Urology
- Vol. 23 (1) , 1-9
Hyaluronic acid injection to coronal sulcus of the penis for the treatment of premature ejaculation: a retrospective observational study
Background: Hyaluronic acid (HA) injection has become a burgeoning method to treat premature ejaculation (PE) due to its high biocompatibility and structural properties.Purpose: In this study, we proposed a modified technique: injecting hyaluronic acid around coronal sulcus to treat PE, aiming to decrease the complications of hyaluronic acid injection in penis while achieving similar effects.Method: A total of 85 patients who had HA injection from January 2018 to December 2019 were analyzed retrospectively in our study. 31 patients received injection at glans penis and 54 patients received injection around coronal sulcus. Intravaginal ejaculation latency time (IELT) was mainly measured to estimate the efficacy and the severity of complications was assessed between two groups.Results: The mean IELT was 123.0 ± 37.28 s of all patients, 124.7 ± 39.01 s of patients injecting at glans penis and 121.9 ± 36.58 s of patients injecting around coronal sulcus. IELT of all patients increased to 482.1 ± 121.7 s at 1 month, 331.2 ± 81.2 s at 3 month and 280 ± 80.4 s at 6 month. In the group of injecting at glans penis, the incidence of complications is 25.8% and it is 1.9% in the group of injecting around coronal sulcus. No severe complication was reported in both groups.Conclusion: The modified technique of injecting around coronal sulcus decreases complications and it has the potential to become a new injectable technique for treating premature ejaculation.
- 1 April 2023
- Published by Springer Nature in BMC Urology
- Vol. 23 (1) , 1-9
Open AccessHyaluronic acid injection to coronal sulcus of the penis for the treatment of premature ejaculation: a retrospective observational study
Background: Hyaluronic acid (HA) injection has become a burgeoning method to treat premature ejaculation (PE) due to its high biocompatibility and structural properties.Purpose: In this study, we proposed a modified technique: injecting hyaluronic acid around coronal sulcus to treat PE, aiming to decrease the complications of hyaluronic acid injection in penis while achieving similar effects.Method: A total of 85 patients who had HA injection from January 2018 to December 2019 were analyzed retrospectively in our study. 31 patients received injection at glans penis and 54 patients received injection around coronal sulcus. Intravaginal ejaculation latency time (IELT) was mainly measured to estimate the efficacy and the severity of complications was assessed between two groups.Results: The mean IELT was 123.0 ± 37.28 s of all patients, 124.7 ± 39.01 s of patients injecting at glans penis and 121.9 ± 36.58 s of patients injecting around coronal sulcus. IELT of all patients increased to 482.1 ± 121.7 s at 1 month, 331.2 ± 81.2 s at 3 month and 280 ± 80.4 s at 6 month. In the group of injecting at glans penis, the incidence of complications is 25.8% and it is 1.9% in the group of injecting around coronal sulcus. No severe complication was reported in both groups.Conclusion: The modified technique of injecting around coronal sulcus decreases complications and it has the potential to become a new injectable technique for treating premature ejaculation.
- Open Access
- 7 September 2022
- Published by Springer Nature in Research Square
Hyaluronic acid injection to coronary sulcus of the penis for the treatment of premature ejaculation
Hyaluronic acid (HA) injection has become a burgeoning method to treat premature ejaculation (PE). In this study, we proposed a modified technique: injecting hyaluronic acid around coronary sulcus to treat premature ejaculation with lowered complications. To improve the current injectable technique to decrease the complications of hyaluronic acid injection in penis while achieving similar effects. A total of 85 patients who had HA injection from January 2018 to December 2019 were analyzed retrospectively in our study. 31 patients received injection at glans penis and 54 patients received injection around coronary sulcus. Intravaginal ejaculation latency time (IELT) was mainly measured to estimate the efficacy and the severity of complications was assessed between two groups. The mean intravaginal ejaculation latency time increased from 123.0±37.28s to 483.5±123.4s at 1 month after intervention, and dropped to 332.7±78.50s and 278.8±67.67s at 3-month follow-up and 6-month follow-up, respectively. In the group of injecting at glans penis, the incidence of complications is 25.8%; it is 1.9% in the group of injecting around coronary sulcus. No severe complication was reported in both groups. modified technique of injecting around coronary sulcus decreases complications and it has the potential to become a new injectable technique for treating premature ejaculation.
- 7 September 2022
- Published by Springer Nature in Research Square
Open AccessHyaluronic acid injection to coronary sulcus of the penis for the treatment of premature ejaculation
Hyaluronic acid (HA) injection has become a burgeoning method to treat premature ejaculation (PE). In this study, we proposed a modified technique: injecting hyaluronic acid around coronary sulcus to treat premature ejaculation with lowered complications. To improve the current injectable technique to decrease the complications of hyaluronic acid injection in penis while achieving similar effects. A total of 85 patients who had HA injection from January 2018 to December 2019 were analyzed retrospectively in our study. 31 patients received injection at glans penis and 54 patients received injection around coronary sulcus. Intravaginal ejaculation latency time (IELT) was mainly measured to estimate the efficacy and the severity of complications was assessed between two groups. The mean intravaginal ejaculation latency time increased from 123.0±37.28s to 483.5±123.4s at 1 month after intervention, and dropped to 332.7±78.50s and 278.8±67.67s at 3-month follow-up and 6-month follow-up, respectively. In the group of injecting at glans penis, the incidence of complications is 25.8%; it is 1.9% in the group of injecting around coronary sulcus. No severe complication was reported in both groups. modified technique of injecting around coronary sulcus decreases complications and it has the potential to become a new injectable technique for treating premature ejaculation.
- 1 August 2022
- Published by Hindawi Limited in Andrologia
- Vol. 54 (7) , e14435
Efficacy and safety assessment of glandular augmentation with hyaluronic acid for premature ejaculation
Glandular augmentation (GA) with hyaluronic acid (HA) is a newly developed, minimally invasive therapy for patients with premature ejaculation (PE); however, evidence supporting its efficacy is scarce. To provide a comprehensive profile of GA with HA gel in managing PE, 184 patients with PE who received GA with HA gel therapy from October 2017 to November 2019 were included and followed up for 1 year. The Fan technique was applied. Intravaginal Ejaculation Latency Time (IELT), Chinese Index of Premature Ejaculation-5(CIPE-5) and Visualised Satisfaction Index (VSI) of sexual experience were assessed at initial and 1-, 3-, 6- and 12-month post injection. A total of 71 patients with primary PE (pPE, 38.6%) and 113 patients with acquired PE (aPE, 61.4%) were enrolled. The mean IELT increased to 100.7 +/- 43.2 s(p < .05) for pPE patients and 359.2 +/- 87.1 s (p < .05) for aPE patients 1-month post injection and remained significantly higher at the end point with acceptable attenuation. The mean CIPE-5 score increased to 17.6 +/- 6.4 (p < .05) in the 1st month and remained steady. The VSI scores increased to 6.6 +/- 1.0 (p < .05) for patients with pPE and 7.7 +/- 1.2 (p < .01) for patients with aPE. Increments in VSI in patients with aPE were significantly higher than those in patients with pPE (p < .01). No severe complications were noted. GA with HA may be an effective and safe method to treat PE. Patients with acquired PE were also more satisfied post treatment.
- 1 August 2022
- Published by Hindawi Limited in Andrologia
- Vol. 54 (7) , e14435
Efficacy and safety assessment of glandular augmentation with hyaluronic acid for premature ejaculation
Glandular augmentation (GA) with hyaluronic acid (HA) is a newly developed, minimally invasive therapy for patients with premature ejaculation (PE); however, evidence supporting its efficacy is scarce. To provide a comprehensive profile of GA with HA gel in managing PE, 184 patients with PE who received GA with HA gel therapy from October 2017 to November 2019 were included and followed up for 1 year. The Fan technique was applied. Intravaginal Ejaculation Latency Time (IELT), Chinese Index of Premature Ejaculation-5(CIPE-5) and Visualised Satisfaction Index (VSI) of sexual experience were assessed at initial and 1-, 3-, 6- and 12-month post injection. A total of 71 patients with primary PE (pPE, 38.6%) and 113 patients with acquired PE (aPE, 61.4%) were enrolled. The mean IELT increased to 100.7 +/- 43.2 s(p < .05) for pPE patients and 359.2 +/- 87.1 s (p < .05) for aPE patients 1-month post injection and remained significantly higher at the end point with acceptable attenuation. The mean CIPE-5 score increased to 17.6 +/- 6.4 (p < .05) in the 1st month and remained steady. The VSI scores increased to 6.6 +/- 1.0 (p < .05) for patients with pPE and 7.7 +/- 1.2 (p < .01) for patients with aPE. Increments in VSI in patients with aPE were significantly higher than those in patients with pPE (p < .01). No severe complications were noted. GA with HA may be an effective and safe method to treat PE. Patients with acquired PE were also more satisfied post treatment.
- Open Access
- 8 April 2022
- Published by Medknow in Asian Journal of Andrology
- Vol. 24 (6) , 601-606
Penile augmentation with injectable hyaluronic acid gel: an alternative choice for small penis syndrome
There is no well-established procedure for the management of small penis syndrome (SPS), especially when psychological interventions fail. This study aimed at systematically evaluating the physical and psychological benefits of penile augmentation (PA) using injectable hyaluronic acid (HA) gel. Thirty-eight patients receiving PA with HA gel from January 2017 to March 2020 were included and followed up for 1 year. Penile size, erectile function, and psychological burden measured by the Index of Male Genital Image (IMGI), Index of International Erectile Function (IIEF), and Beliefs about Penis Size (BPAS), respectively, were assessed at the beginning and at 1, 3, 6, and 12 months postinjection. The volume of HA gel injected was 21.5 ± 3.7 ml. Compared to baseline data, flaccid penile girth and length significantly increased by 3.41 ± 0.95 cm (P < 0.01) and 2.55 ± 0.55 cm (P < 0.01) at the 1st month postinjection, respectively. At the endpoint, despite attenuations, statistically significant improvements in flaccid penis size were still obtained, namely 2.44 ± 1.14 cm in girth (P < 0.01) and 1.65 ± 0.59 cm in length (P < 0.01). Similarly, erectile penile girth statistically increased by 1.32 ± 1.02 cm (P < 0.01) at the 1st month but were only 0.80 ± 0.54 cm bigger than baseline (P < 0.01) at the endpoint. At the 1st month, the average score of IMGI and the mean score of IIEF statistically increased by 46.2 ± 10.5 (P < 0.01) and 7.6 ± 6.2 (P < 0.01), respectively; the score of BAPS significantly decreased by 18.3 ± 4.5 (P < 0.01). These alterations remained steady during follow-up. Considering the significant penile size improvement, lasting psychological benefit, and low complication rate, PA with HA might serve as an appropriate alternative for patients with SPS.
- 8 April 2022
- Published by Medknow in Asian Journal of Andrology
- Vol. 24 (6) , 601-606
Open AccessPenile augmentation with injectable hyaluronic acid gel: an alternative choice for small penis syndrome
There is no well-established procedure for the management of small penis syndrome (SPS), especially when psychological interventions fail. This study aimed at systematically evaluating the physical and psychological benefits of penile augmentation (PA) using injectable hyaluronic acid (HA) gel. Thirty-eight patients receiving PA with HA gel from January 2017 to March 2020 were included and followed up for 1 year. Penile size, erectile function, and psychological burden measured by the Index of Male Genital Image (IMGI), Index of International Erectile Function (IIEF), and Beliefs about Penis Size (BPAS), respectively, were assessed at the beginning and at 1, 3, 6, and 12 months postinjection. The volume of HA gel injected was 21.5 ± 3.7 ml. Compared to baseline data, flaccid penile girth and length significantly increased by 3.41 ± 0.95 cm (P < 0.01) and 2.55 ± 0.55 cm (P < 0.01) at the 1st month postinjection, respectively. At the endpoint, despite attenuations, statistically significant improvements in flaccid penis size were still obtained, namely 2.44 ± 1.14 cm in girth (P < 0.01) and 1.65 ± 0.59 cm in length (P < 0.01). Similarly, erectile penile girth statistically increased by 1.32 ± 1.02 cm (P < 0.01) at the 1st month but were only 0.80 ± 0.54 cm bigger than baseline (P < 0.01) at the endpoint. At the 1st month, the average score of IMGI and the mean score of IIEF statistically increased by 46.2 ± 10.5 (P < 0.01) and 7.6 ± 6.2 (P < 0.01), respectively; the score of BAPS significantly decreased by 18.3 ± 4.5 (P < 0.01). These alterations remained steady during follow-up. Considering the significant penile size improvement, lasting psychological benefit, and low complication rate, PA with HA might serve as an appropriate alternative for patients with SPS.
- Open Access
- 1 January 2022
- Published by Wiley in BioMed Research International
- Vol. 2022 (1) , 4990184
Immunoregulatory Therapy Improves Reproductive Outcomes in Elevated Th1/Th2 Women with Embryo Transfer Failure
Objective. Immunological disturbance is one of the crucial factors of implantation failure. Limited data exists evaluating immunoregulatory therapy in patients with implantation failures. Methods. This is a retrospective cohort study on patients who had failed embryo transfer cycle and had elevated Th1/Th2 cytokine ratios between 1/2019 and 3/2020. Patients were assigned into two groups based on whether they received immunoregulatory treatment during a frozen transfer cycle. The primary outcome was live birth rate. Secondary outcomes included clinical pregnancy, implantation rate, and neonatal outcomes. Results. Of 71 patients enrolled, 41 patients received immunoregulatory therapy and 30 patients did not. Compared to untreated patients, rate of live birth was significantly elevated in the treated group (41.5% vs. 16.7%, P = 0.026). Rate of biochemical pregnancy, implantation, clinical pregnancy, and ongoing pregnancy between two groups were 56.1% vs. 40% (P = 0.18), 36.5% vs. 23.9% (P = 0.15), 51.2% vs. 30% (P = 0.074), and 41.5% vs. 16.7% (P = 0.03), respectively. Although there was no statistical significance, women receiving treatment also had a tendency of lower frequency of pregnancy loss (19.0% vs. 44.4%, P = 0.20). No adverse events were found between newborns of the two groups. Immunoregulatory therapy, age, infertility type, ovulation induction protocol, number of oocytes retrieved, artificial cycle embryo transfer, and cleavage transfer were associated with live birth in univariate analysis (all P < 0.05). Only immunoregulatory therapy was associated with live birth after adjustment of confounders (OR = 5.02, 95% CI: 1.02‐24.8, P = 0.048). Conclusions. Immunoregulatory therapy improves reproductive outcomes in elevated Th1/Th2 cytokine ratio women with embryo transfer failure.
- 1 January 2022
- Published by Wiley in BioMed Research International
- Vol. 2022 (1) , 4990184
Open AccessImmunoregulatory Therapy Improves Reproductive Outcomes in Elevated Th1/Th2 Women with Embryo Transfer Failure
Objective. Immunological disturbance is one of the crucial factors of implantation failure. Limited data exists evaluating immunoregulatory therapy in patients with implantation failures. Methods. This is a retrospective cohort study on patients who had failed embryo transfer cycle and had elevated Th1/Th2 cytokine ratios between 1/2019 and 3/2020. Patients were assigned into two groups based on whether they received immunoregulatory treatment during a frozen transfer cycle. The primary outcome was live birth rate. Secondary outcomes included clinical pregnancy, implantation rate, and neonatal outcomes. Results. Of 71 patients enrolled, 41 patients received immunoregulatory therapy and 30 patients did not. Compared to untreated patients, rate of live birth was significantly elevated in the treated group (41.5% vs. 16.7%, P = 0.026). Rate of biochemical pregnancy, implantation, clinical pregnancy, and ongoing pregnancy between two groups were 56.1% vs. 40% (P = 0.18), 36.5% vs. 23.9% (P = 0.15), 51.2% vs. 30% (P = 0.074), and 41.5% vs. 16.7% (P = 0.03), respectively. Although there was no statistical significance, women receiving treatment also had a tendency of lower frequency of pregnancy loss (19.0% vs. 44.4%, P = 0.20). No adverse events were found between newborns of the two groups. Immunoregulatory therapy, age, infertility type, ovulation induction protocol, number of oocytes retrieved, artificial cycle embryo transfer, and cleavage transfer were associated with live birth in univariate analysis (all P < 0.05). Only immunoregulatory therapy was associated with live birth after adjustment of confounders (OR = 5.02, 95% CI: 1.02‐24.8, P = 0.048). Conclusions. Immunoregulatory therapy improves reproductive outcomes in elevated Th1/Th2 cytokine ratio women with embryo transfer failure.
- Open Access
- 1 July 2021
- Published by Medknow in Asian Journal of Andrology
- Vol. 23 (4) , 392-395
Complications and management of penile augmentation with hyaluronic acid injection
Hyaluronic acid injection is becoming a popular way for penile augmentation. However, only few studies and follow-ups have investigated the various complications of hyaluronic acid injection and their corresponding management. In this study, a total of 230 patients who had penile augmentation with hyaluronic acid injection from January 2018 to December 2019 were examined on follow-up for penile girth, complications, and their corresponding management. At 1-month, 3-month, and 6-month postoperative follow-ups, the penile circumference had increased by 2.66 ± 1.24 cm, 2.28 ± 1.02 cm, and 1.80 ± 0.83 cm, respectively. During the entire 6-month follow-up, 4.3% had complications such as subcutaneous bleeding, subcutaneous nodules, and infection. There were no systemic or local allergic reactions among all the patients. All complications were treated accordingly, and no further deterioration or severe sequelae were observed. Although complications of hyaluronic acid injections are mild and rare, these may affect the patient's satisfaction postoperatively. Preoperative redundant prepuce may increase the incidence of penile edema or postoperative gel migration. Standardization of the surgery protocol and elucidation of the effects of other injection parameters are still lacking. Nevertheless, it still highlights the importance of preoperative preparation and surgical technique.
- 1 July 2021
- Published by Medknow in Asian Journal of Andrology
- Vol. 23 (4) , 392-395
Open AccessComplications and management of penile augmentation with hyaluronic acid injection
Hyaluronic acid injection is becoming a popular way for penile augmentation. However, only few studies and follow-ups have investigated the various complications of hyaluronic acid injection and their corresponding management. In this study, a total of 230 patients who had penile augmentation with hyaluronic acid injection from January 2018 to December 2019 were examined on follow-up for penile girth, complications, and their corresponding management. At 1-month, 3-month, and 6-month postoperative follow-ups, the penile circumference had increased by 2.66 ± 1.24 cm, 2.28 ± 1.02 cm, and 1.80 ± 0.83 cm, respectively. During the entire 6-month follow-up, 4.3% had complications such as subcutaneous bleeding, subcutaneous nodules, and infection. There were no systemic or local allergic reactions among all the patients. All complications were treated accordingly, and no further deterioration or severe sequelae were observed. Although complications of hyaluronic acid injections are mild and rare, these may affect the patient's satisfaction postoperatively. Preoperative redundant prepuce may increase the incidence of penile edema or postoperative gel migration. Standardization of the surgery protocol and elucidation of the effects of other injection parameters are still lacking. Nevertheless, it still highlights the importance of preoperative preparation and surgical technique.
- Open Access
- 10 November 2020
- Published by Springer Nature in BMC Urology
- Vol. 20 (1) , 1-6
Multivariate analysis of factors for failed continuous bladder irrigation in hemorrhagic cystitis patients after hematopoietic stem cell transplantation
Background: Continuous bladder irrigation (CBI) and proper adjustment of saline irrigation speed are important to avoid CBI failure in hemorrhagic cystitis (HC) patients after allogeneic hematopoietic stem cell transplantation (HSCT). Nevertheless, too fast irrigation speed could take away the patient's much heat, contribute to blood coagulopathy, and increase the nursing workload. Evaluation of risk for CBI failure remains an unmet clinical need. Methods: The general information, clinical characteristics, and consultation records of HC patients in 1380 patients with hematopoietic stem cell transplantation in our center from 2017 to 2019 were analyzed retrospectively. The receiver operating characteristic (ROC) curve was used to calculate the cutoff point of the continuous variable, and multivariate logistic regression was used to analyze the risk factors affecting CBI failure in HC patients. Results: The incidence of HC after HSCT was 23%. A total of 227 patients with HC above grade 2 were included. Univariate analysis showed that CRP, age, platelet counts, onset time after transplantation, albumin, and hemoglobin were associated with CBI failure in the short-term (P < 0.05). ROC curve and multivariate logistic regression analysis showed that CRP > 8.89 ng/ml (RR = 7.828, 95% CI 2.885–21.244), age < 14.5 years (RR = 9.940, 95% CI 3.219–30.697), and onset time of HC > 37d after transplantation (RR = 7.021, 95% CI 2.204–22.364), were independent risk factors for failure of CBI (P < 0.05). Conclusions: The study identified CRP > 8.89 ng/ml, age < 14.5 years, and onset time of HC after HSCT > 37d are independent factors for failure of CBI, which could be combined to allow stratification of HC after HSCT patients into low-, intermediate- and high-risk subgroups of CBI failure.
- 10 November 2020
- Published by Springer Nature in BMC Urology
- Vol. 20 (1) , 1-6
Open AccessMultivariate analysis of factors for failed continuous bladder irrigation in hemorrhagic cystitis patients after hematopoietic stem cell transplantation
Background: Continuous bladder irrigation (CBI) and proper adjustment of saline irrigation speed are important to avoid CBI failure in hemorrhagic cystitis (HC) patients after allogeneic hematopoietic stem cell transplantation (HSCT). Nevertheless, too fast irrigation speed could take away the patient's much heat, contribute to blood coagulopathy, and increase the nursing workload. Evaluation of risk for CBI failure remains an unmet clinical need. Methods: The general information, clinical characteristics, and consultation records of HC patients in 1380 patients with hematopoietic stem cell transplantation in our center from 2017 to 2019 were analyzed retrospectively. The receiver operating characteristic (ROC) curve was used to calculate the cutoff point of the continuous variable, and multivariate logistic regression was used to analyze the risk factors affecting CBI failure in HC patients. Results: The incidence of HC after HSCT was 23%. A total of 227 patients with HC above grade 2 were included. Univariate analysis showed that CRP, age, platelet counts, onset time after transplantation, albumin, and hemoglobin were associated with CBI failure in the short-term (P < 0.05). ROC curve and multivariate logistic regression analysis showed that CRP > 8.89 ng/ml (RR = 7.828, 95% CI 2.885–21.244), age < 14.5 years (RR = 9.940, 95% CI 3.219–30.697), and onset time of HC > 37d after transplantation (RR = 7.021, 95% CI 2.204–22.364), were independent risk factors for failure of CBI (P < 0.05). Conclusions: The study identified CRP > 8.89 ng/ml, age < 14.5 years, and onset time of HC after HSCT > 37d are independent factors for failure of CBI, which could be combined to allow stratification of HC after HSCT patients into low-, intermediate- and high-risk subgroups of CBI failure.
- Open Access
- 4 June 2020
- Published by SAGE Publications in Plastic Surgery
- Vol. 28 (3) , 161-166
Human Acellular Dermal Matrix Augmentation Phalloplasty Surgery
Introduction and Objective: Many men often have the need to enlarge their penises for psychological gain and to satisfy or to impress their partners. Many surgical techniques have been reported. However, none is the gold standard. Aim: To evaluate the efficacy and safety of human acellular dermal matrix allograft in augmentation phalloplasty technique. Methods: From March 2015 to September 2017, a total of 182 patients were prospectively recruited into our cohort after complete physical and psychological evaluation that deemed suitable for penile enhancement. Penis circumference was measured at the mid-length of the penis. Mean was 7.03 cm (6.93 ± 1.00 cm) and 12.1 cm (10.59 ± 1.15 cm) during flaccid and erection, respectively. All patients received human acellular dermal matrix graft under spinal or local anesthesia. The allograft was preconditioned in normal saline for 20 minutes, and mesh incisions were made to optimize blood flow. The width was equal to the circumference of both corpus cavernosa but without corpus spongiosum. The length of the graft was determined by measuring the length between the tip of the coronary sulcus and the root of penis. A complete incision below the coronary sulcus to the depth of the Buck’s fascia was made. Then separate the dartos fascia from the Buck’s fascia. The prepared graft was then placed on top of the Buck’s fascia, with the blood-remained side facing the Buck’s fascia. The graft was sutured using 4-0 absorbable polyglycolic acid suture to the Buck’s fascia. Extra caution needed to be taken when fixing ventrally to avoid injuring the urethra. Once completed, the dartos fascia was restored, the dartos fascia and subcutaneous tissue were sutured with 4-0 absorbable suture, and skin closure is achieved subsequently. Results: The post-operative course was without complications. At the follow-up after 1 year, the mean flaccid girth increased to 8.07 ± 1.06 cm ( P < .05), while the mean erect girth increased to 12.79 ± 1.23 cm ( P < .05). Sexual activity was allowed after 8 weeks of surgery. The majority reported that sexual self-esteem and functioning significantly improved. In addition, 59 patients reported alleviation of premature ejaculation. Conclusions: Compared to autologous dermis-fat graft and xenograft, augmentation phalloplasty using human acellular dermal matrix has several advantages: (1) it avoids harm harvesting site of the autograft; (2) the effects of dermis allograft can last at least 1 year; and (3) acellular dermal matrix is more likely to be accepted by people.
- 4 June 2020
- Published by SAGE Publications in Plastic Surgery
- Vol. 28 (3) , 161-166
Open AccessHuman Acellular Dermal Matrix Augmentation Phalloplasty Surgery
Introduction and Objective: Many men often have the need to enlarge their penises for psychological gain and to satisfy or to impress their partners. Many surgical techniques have been reported. However, none is the gold standard. Aim: To evaluate the efficacy and safety of human acellular dermal matrix allograft in augmentation phalloplasty technique. Methods: From March 2015 to September 2017, a total of 182 patients were prospectively recruited into our cohort after complete physical and psychological evaluation that deemed suitable for penile enhancement. Penis circumference was measured at the mid-length of the penis. Mean was 7.03 cm (6.93 ± 1.00 cm) and 12.1 cm (10.59 ± 1.15 cm) during flaccid and erection, respectively. All patients received human acellular dermal matrix graft under spinal or local anesthesia. The allograft was preconditioned in normal saline for 20 minutes, and mesh incisions were made to optimize blood flow. The width was equal to the circumference of both corpus cavernosa but without corpus spongiosum. The length of the graft was determined by measuring the length between the tip of the coronary sulcus and the root of penis. A complete incision below the coronary sulcus to the depth of the Buck’s fascia was made. Then separate the dartos fascia from the Buck’s fascia. The prepared graft was then placed on top of the Buck’s fascia, with the blood-remained side facing the Buck’s fascia. The graft was sutured using 4-0 absorbable polyglycolic acid suture to the Buck’s fascia. Extra caution needed to be taken when fixing ventrally to avoid injuring the urethra. Once completed, the dartos fascia was restored, the dartos fascia and subcutaneous tissue were sutured with 4-0 absorbable suture, and skin closure is achieved subsequently. Results: The post-operative course was without complications. At the follow-up after 1 year, the mean flaccid girth increased to 8.07 ± 1.06 cm ( P < .05), while the mean erect girth increased to 12.79 ± 1.23 cm ( P < .05). Sexual activity was allowed after 8 weeks of surgery. The majority reported that sexual self-esteem and functioning significantly improved. In addition, 59 patients reported alleviation of premature ejaculation. Conclusions: Compared to autologous dermis-fat graft and xenograft, augmentation phalloplasty using human acellular dermal matrix has several advantages: (1) it avoids harm harvesting site of the autograft; (2) the effects of dermis allograft can last at least 1 year; and (3) acellular dermal matrix is more likely to be accepted by people.